Summer Speaker Series: Life After KGI with Rachel Knight MBS ’11 and Thomas Tredennick, MBS ’10

Rachel Knight, MBS ’11, is the Director of Business Development at Amgen. In her eight years at Amgen, she previously worked as the Director of General Medicine Forecasting and held senior manager positions in forecasting, strategic planning and operations. Prior to that, she worked at L.E.K. Consulting, working on a variety of pharmaceutical, medical device and diagnostic projects on market sizing, revenue forecasting, pricing and strategic planning. Knight holds a Master of Business and Science (MBS) from KGI and a BA in Biological Sciences from the University of Chicago.

Thomas Tredennick, MBS ’10, is currently the owner and managing partner of La Verne Brewing Company, a small brewery based in La Verne, CA. Additionally, Tredennick is the associate director of Strategic Supply Chain for Arsenal Bio, a company that works to discover, develop, and commercialize curative immune cell therapies and is based in the South San Francisco area. Before Arsenal Bio, he was a senior project manager in Process Development for the Product Life Cycle Management Team at Kite Pharma, where he managed CMC activities for early-stage products. Kite Pharma is a biotechnology company developing cancer immunotherapy products. Prior to joining Kite Pharma, Tredennick worked as a project manager for Vetter Pharma, working with early-stage biotechnology firms to manufacture biologics for Phase 1 and Pre-Clinical studies. Previous to Vetter, Tredennick worked at Baxter, later Baxalta, as a project manager leading international technology transfer projects. Tredennick holds a Master of Business and Science (MBS) from KGI and a BS in Biological Engineering from Cornell University.

*This is a hybrid event. Please register by using the virtual registration link or the in-person link.

Virtual Registration